{
    "Title": "Access to Chagas disease treatment in the United States after the regulatory approval of benznidazole",
    "URL": "https://doi.org/10.1371/journal.pntd.0008398",
    "Published": "June 22, 2020",
    "Subject_Areas": [
        "Physicians",
        "Chagas disease",
        "Health insurance",
        "Drug therapy",
        "Health care providers",
        "Treatment guidelines",
        "Trypanosoma cruzi",
        "Finance"
    ],
    "Authors": {
        "Kota Yoshioka": [
            "Doctor of Public Health Program, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America"
        ],
        "Jennifer Manne-Goehler": [
            "Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America"
        ],
        "James H. Maguire": [
            "Division of Infectious Disease, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America"
        ],
        "Michael R. Reich": [
            "Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America"
        ]
    }
}